- Fee assured
- Verified this account
- Urological malignancy
Greg Shaw qualified in medicine at St Bartholomews Medical College in 1999. His focus on prostate cancer started with an MD research degree at St Bartholomew's Hospital in 2005. Thereafter he trained as a Urologist in North London where he earned Fellowship of the Royal College of Surgeons of England. In order to further develop his interest in prostate cancer he took up a 4 year Lectureship at The University of Cambridge working in a world class research team and generating important findings from his research. In Cambridge Greg began to develop his interest in robotic surgery which was consolidated through the prestigious Royal College of Surgeons of England Fellowship program. Now a consultant at University College Hospital and St Bartholomew's Hospital, Greg uses his scientific training to interpret the latest evidence regarding prostate cancer diagnosis and treatment, to provide the best possible care for patients suspected of having, or proven to have a diagnosis of prostate cancer.
His private practice includes the investigation of common problems such as blood in the urine, difficulty in urination, raised PSA levels and urinary tract infections. In his Private Practice, he investigates, diagnoses and treats patients with prostate and bladder cancer. He uses a range of biopsy approaches including transperineal and MRI guided, to diagnose prostate cancer. He also performs benign prostate surgery and inguino-scrotal surgery.
He takes pride in establishing positive therapeutic relationships with his patients and their families.
He performs 150 robotic prostatectomies per year, amongst the highest rate for UK urologists. Greg is known for evaluating and using the best technical modifications to attain excellent results for his patients.
Areas of interest
Prostate Cancer Diagnostics, Prostate cancer, Prostate MRI, Prostate biopsy- Transrectal prostate biopsy, Transperineal prostate biopsy, Targetted prostate biopsy, prostate biopsy for prostate cancer; MRI prostate for prostate cancer, Targeted prostate biopsy for prostate cancer, Transperineal prostate biopsy for accurate prostate cancer mapping;
Prostate cancer treatment, Robotic prostatectomy, active surveillance, active surveillance of prostate cancer, clinical trials, second opinion for prostate cancer options;
Urinary problems- Recurrent urinary tract infection, Lower urinary tract symptoms,
Haematuria, Raised prostate specific antigen (PSA); Urinary/urine symptoms, 'prostatism', urethral stricture, bladder neck stenosis/stricture, TURP;
Peno-Scrotal Surgery (Circumcision, Vasectomy, Epididymal Cysts, Hydroceles, Orchidectomy, Orchidopexy, Foreskin problems, Vasectomy)
Current NHS consultant posts held
Consultant Urologist and Specialist in Robotic Surgery, University College Hospitals NHS Trust
Honorary Consultant Urologist, Bartshealth NHS Trust
Prostate cancer- risk stratification
Active surveillance- Chief Investigator on the PROVENT clinical trial.
Lead on national research initiative to evaluate the NeuroSAFE intraoperative frozen section procedure to promote nerve sparing during radical prostatectomy.
Keen footballer and skiier
Best poster, BAUS 2016
Best Videoposter, BAUS 2015
Best Paper & Best Poster, BAUS 2013
Best Poster, AUA 2013
First Prize, Best Scientific Abstract & Best poster, EAU 2013
Academy of Medical Sciences grant £29,000 2011
Western Section AUA. Grand Prize Overall Winner, Hawaii. 2006.
“Top Ten” presentation- SIU October 2005.
Young Scientist of the Year Award, International Soc. for Urolithiasis, 2004.
The Inspire Foundation. £35,000 grant 2003
The Tallow Chandlers Award, 1998
English and conversational Italian
41 peer reviewed articles including:
Apparatus for Histological Validation of Magnetic Resonance Imaging of the Human Prostate. Front. Oncol. 2017
PSA screening improves outcome for men with locally advanced and high risk prostate cancer. Data from the ProtecT trial. European Urology 2017 (In the top 5% of all research outputs scored by Altmetric)
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS1H NMR spectroscopy. Metabolomics (2016)
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre. BJU Int. 2016 Apr 28.PMID 27124625
The rapid effects of castration on human prostate cancer. Eur Urol. 2015 Nov 10 PMID: 26572708
Intraoperative frozen section of the prostate to reduces the risk of positive margin whilst ensuring nerve sparing Curr Urol. 2016 PMID: 27390582
Choline kinase alpha is an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target. J Natl Cancer Inst. 2015 Dec 11;108(5). 2016 May. PMID:26657335
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men. Br J Cancer. 2014 May PMID: 24722183
Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22,393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol. 2013 Nov 24. PMID: 24290695.
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network. EMBO Mol Med. 2014 May PMID: 24737870
Optimal therapy for high risk localised prostate cancer - should surgery be an option or a preferred primary treatment? BJU Int. 2011 PMID: 21951841
High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multi-focal prostate cancer. Genes Chromosomes Cancer. 2012 PMID: 22334418.
Multi-parametric Magnetic Resonance Imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int. 2011 PMID: 21701136
Shaw GL and Neal D, Chapter 73 The Prostate and Seminal Vesicles. Bailey and Love’s Short Practice of Surgery 27th Edition. Edward Arnold 2016
Shaw GL. Neal DE. “Molecular Biology of Prostate cancer”, in Tewari A Prostate Cancer: A Comprehensive Perspective Elselvier 2011
Courses offered to GPs
Improving diagnostic accuracy in prostate cancer.
Robotic surgery for improved outcomes in prostate cancer.
- MD Prostate cancer basic research University of London 2006
- MBBS University of London 1999
- FRCS (urol) Royal College of Surgeons 2010
- MRCS Royal College of Surgeons of England 2004
- Fellowship in Robotic surgery Royal College of Surgeons of England 2014
Reference number 4626222
Details of entry to specialist register
- Urology, 2012
Affiliations / memberships
British Association of Urology
European Association of Urology
Fellow of the Royal College of Surgeons of England
- 17-19 View RoadLONDONN6 4DJ
- 12:00 - 15:00
- 07954 007540
- 42-52 Nottingham PlaceLONDONW1U 5NY
- 09:30 - 11:30
- 07954 007540
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
9-5 Private Secretary (Sam Thornton) 07954 007540. Out of hours contact the hospital where surgery was performed who are able to contact me.